Skip to main content
. 2020 Oct-Dec;13(4):326–332. doi: 10.4103/JCAS.JCAS_39_20

Table 1.

Mode of treatment in three groups

A B C
Vitamin D3 (0.2 mL, 15 mg/mL) + lignocaine (0.2 mL, 20 mg/mL) MR vaccine (0.5 mL/dose) 5 TU of tuberculin PPD 0.1 mL/dose
15 15 15

MR, measles rubella vaccine; PPD, purified protein derivative